Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacoepidemiologic General Research Extension: PGRx-sIBM Study

NCT02735447 is registered in ClinicalTrials.gov with La-ser Europe Limited as lead sponsor.

NCT NCT02735447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02735447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacoepidemiologic General Research Extension: PGRx-sIBM Study
Lead sponsor
La-ser Europe Limited
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2016
Completion date
February 28, 2017
Enrollment
190 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sporadic inclusion body myositis